

According to IQ4I analysis, the hernia repair devices global market is estimated to grow at low single-digit CAGR from 2020 to 2027 to reach $4,400.1 million by 2027. An increasing number of patients suffering from obesity and the rise in the aging population who are vulnerable to develop hernia, rising adoption of tension-free repair procedures and increasing demand for minimally invasive procedures, are driving the growth of hernia repair devices market. However, inconsistent reimbursement and the high cost of the hernia repair procedure, high implementation cost and regulations posed on robotic surgery, operation failure and recurrence of hernia and also the risks and complications associated with hernia repair surgery and meshes are negatively influencing the expansion of hernia repair devices market.
The Hernia repair devices global market is segmented based on products, hernia types, repair types, end-users and geography. The market by product is segmented into hernia fixation devices, and hernia repair meshes, among them, hernia repair meshes accounted for the largest revenue in 2020 and is expected to grow at low single-digit CAGR from 2020 to 2027 due to increased adoption of mesh based surgeries.
The hernia repair meshes market is further segmented into synthetic, biological and composite meshes. Among them, synthetic mesh segment dominated the market with largest revenue in 2020 and composite mesh segment is expected to grow at mid single-digit CAGR from 2020 to 2027 due to efficiency and lower cost. The synthetic mesh market is further sub-segmented into the absorbable and non-absorbable mesh. Among them, non-absorbable mesh contributed the largest revenue in 2020 and is expected to grow at mid single-digit CAGR from 2020 to 2027 due to the mechanical strength and lower cost when compared to absorbable meshes. The composite mesh market is further sub-segmented into absorbable, non-absorbable and partially absorbable meshes, of which, absorbable meshes generated the largest revenue in 2020 and is expected to grow at mid single-digit CAGR from 2020 to 2027.
Based on the hernia type, the market is segmented into the inguinal hernia, incisional hernia, umbilical hernia and other types of hernia (Femoral, Epigastric, Hiatal, Obturator, Spigelian and Muscle). Among them, inguinal hernia contributed the largest revenue in 2020 and incisional hernia is expected to grow at moderate CAGR from 2020 to 2027 due to higher incidence of inguinal hernia in persons who have undergone prior abdominal surgery, traumatic abdominal wall injuries and in patients who have undergone C-sections.
Based on the types of repair procedures, the market is divided into open tension-free repair, laparoscopic repair and robotic-assisted hernia repair types. Among these, open-tension free repair occupies the largest share of the market by generating the revenue in 2020 and robotic-assisted surgery is expected to grow at high single-digit CAGR from 2020 to 2027 due to the increased adoption of minimally invasive techniques and early recovery as compared to open tension-free repair.
By end-user, the market is segmented into hospitals and ambulatory surgical centers. Among which, hospitals occupied the largest share in 2020 and ambulatory surgical centers are expected to grow at mid single-digit CAGR from 2020 to 2027 due to advantages such as reduced hospital stays and hence less overall cost.
Geographically, the hernia repair devices global market segmented into North America, Europe, Asia-Pacific and Rest of the World. Among them, North America region commanded the largest share of the hernia repair devices global market in 2020 due to highly advanced healthcare facilities, increase in awareness about the advanced technologies, availability of Medicare and third-party insurance facilities, and easy availability of skilled personnel. Asia-Pacific is expected to grow at mid single-digit CAGR from 2020 to 2027 due to rising adoption of tension-free repair procedures, increasing access to advanced healthcare technology and affordability and increase in population who are vulnerable to develop hernia.
The major companies in hernia repair devices global market are Becton, Dickinson and Company (Bard) (U.S.), Medtronic, PLC (Ireland), Johnson & Johnson (Ethicon) (U.S.), Cook Medical, Inc. (U.S.), Integra Lifesciences (U.S.), B. Braun Melsungen AG, (Germany), SecQure, Inc. (U.S.), AbbVie (Allergan) (Life-cell corporation) (U.S.), W. L. Gore and associates (U.S.) and Tela Bio (U.S.).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 SCOPE OF THE REPORT
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY
ÌýÌý2.6.1 MARKET SIZE ESTIMATION
ÌýÌý2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
ÌýÌý2.6.3 SECONDARY SOURCES
ÌýÌý2.6.4 PRIMARY SOURCES
ÌýÌý2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
ÌýÌý2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
ÌýÌý2.6.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
ÌýÌý3.3.1 DRIVERS AND OPPORTUNITIES
ÌýÌýÌýÌý3.3.1.1 Increasing demand for minimally-invasive procedures
ÌýÌýÌýÌý3.3.1.2 High incidence of hernia associated with change in lifestyle and other diseases
ÌýÌýÌýÌý3.3.1.3 Rise in aging population
ÌýÌýÌýÌý3.3.1.4 Rising adoption of tension-free repair procedures
ÌýÌýÌýÌý3.3.1.5 Opportunities in emerging economies
ÌýÌýÌýÌý3.3.1.6 Hernia repair devices manufacturers' strategic tie-ups with robotic surgery equipment manufacturers
ÌýÌý3.3.2 RESTRAINTS AND THREATS
ÌýÌýÌýÌý3.3.2.1 Complications of hernia repair surgery and mesh
ÌýÌýÌýÌý3.3.2.2 Product recalls due to various quality concerns
ÌýÌýÌýÌý3.3.2.3 Lack of standardization in treatment of hernia
ÌýÌýÌýÌý3.3.2.4 Inconsistent reimbursement and high cost of hernia repair procedure
ÌýÌýÌýÌý3.3.2.5 Stringent regulations associated with approvals of hernia mesh
3.4 REGULATORY AFFAIRS
ÌýÌý3.4.1 THE U.S.
ÌýÌý3.4.2 EUROPE
ÌýÌý3.4.3 CHINA
ÌýÌý3.4.4 INDIA
ÌýÌý3.4.5 JAPAN
3.5 PORTER’S FIVE FORCE ANALYSIS
ÌýÌý3.5.1 THREAT OF NEW ENTRANTS
ÌýÌý3.5.2 THREAT OF SUBSTITUTES
ÌýÌý3.5.3 BARGAINING POWER OF SUPPLIERS
ÌýÌý3.5.4 BARGAINING POWER OF BUYERS
ÌýÌý3.5.5 COMPETITIVE RIVALRY
3.6 CLINICAL TRIALS
3.7 MARKET SHARE ANALYSIS
ÌýÌý3.7.1 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
ÌýÌý3.7.2 SYNTHETIC MESH MARKET SHARE ANALYSIS
ÌýÌý3.7.3 COMPOSITE MESH MARKET SHARE ANALYSIS
ÌýÌý3.7.4 BIOLOGICAL MESH MARKET SHARE ANALYSIS
3.8 HERNIA REPAIR DEVICES NUMBER OF PROCEDURES PERFORMED
4 HERNIA REPAIR DEVICES GLOBAL MARKET, BY PRODUCT TYPE
4.1 INTRODUCTION
4.2 HERNIA FIXATION DEVICES
4.3 HERNIA REPAIR MESHES
ÌýÌý4.3.1 SYNTHETIC MESHES
ÌýÌýÌýÌý4.3.1.1 Absorbable meshes
ÌýÌýÌýÌý4.3.1.2 Non-absorbable meshes
ÌýÌý4.3.2 BIOLOGICAL MESHES
ÌýÌý4.3.3 COMPOSITE MESHES
ÌýÌýÌýÌý4.3.3.1 Absorbable composite mesh
ÌýÌýÌýÌý4.3.3.2 Non-absorbable composite mesh
ÌýÌýÌýÌý4.3.3.3 Partially absorbable composite mesh
5 HERNIA REPAIR DEVICES MARKET, BY HERNIA TYPE
5.1 INTRODUCTION
5.2 INGUINAL HERNIA
5.3 INCISIONAL HERNIA
5.4 UMBILICAL HERNIA
5.5 OTHERS (FEMORAL, EPIGASTRIC, HIATAL, OBTURATOR, SPIGELIAN AND MUSCLE)
6 HERNIA REPAIR DEVICES MARKET, BY REPAIR TYPE
6.1 INTRODUCTION
6.2 OPEN-TENSION FREE REPAIR
6.3 LAPAROSCOPIC HERNIA REPAIR
6.4 ROBOTIC-ASSISTED HERNIA REPAIR
7 HERNIA REPAIR DEVICES MARKET, BY END USERS
7.1 INTRODUCTION
7.2 HOSPITALS
7.3 AMBULATORY SURGICAL CENTERS
8 HERNIA REPAIR DEVICES MARKET, BY REGION
8.1 INTRODUCTION
8.2 NORTH AMERICA
ÌýÌý8.2.1 U.S.
ÌýÌý8.2.2 REST OF NORTH AMERICA
8.3 EUROPE
ÌýÌý8.3.1 GERMANY
ÌýÌý8.3.2 FRANCE
ÌýÌý8.3.3 RUSSIA
ÌýÌý8.3.4 REST OF EUROPE
8.4 ASIA -PACIFIC
ÌýÌý8.4.1 CHINA
ÌýÌý8.4.2 JAPAN
ÌýÌý8.4.3 INDIA
ÌýÌý8.4.4 REST OF APAC
8.5 REST OF THE WORLD
ÌýÌý8.5.1 BRAZIL
ÌýÌý8.5.2 TURKEY
ÌýÌý8.5.3 REST OF LATIN AMERICA, MIDDLE EAST, AND AFRICA
9 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 ACQUISITION
9.3 APPROVALS
9.4 AGREEMENTS AND COLLABORATION
9.5 NEW PRODUCT LAUNCH
9.6 OTHERS
10 MAJOR COMPANIES
10.1 ALLERGAN, PLC (ABBVIE)
ÌýÌý10.1.1 OVERVIEW
ÌýÌý10.1.2 FINANCIALS
ÌýÌý10.1.3 PRODUCT PORTFOLIO
ÌýÌý10.1.4 KEY DEVELOPMENTS
ÌýÌý10.1.5 BUSINESS STRATEGY
ÌýÌý10.1.6 SWOT ANALYSIS
10.2 B. BRAUN MELSUNGEN AG
ÌýÌý10.2.1 OVERVIEW
ÌýÌý10.2.2 FINANCIALS
ÌýÌý10.2.3 PRODUCT PORTFOLIO
ÌýÌý10.2.4 KEY DEVELOPMENTS
ÌýÌý10.2.5 BUSINESS STRATEGY
ÌýÌý10.2.6 SWOT ANALYSIS
10.3 BECTON, DICKINSON AND COMPANY
ÌýÌý10.3.1 OVERVIEW
ÌýÌý10.3.2 FINANCIALS
ÌýÌý10.3.3 PRODUCT PORTFOLIO
ÌýÌý10.3.4 KEY DEVELOPMENTS
ÌýÌý10.3.5 BUSINESS STRATEGY
ÌýÌý10.3.6 SWOT ANALYSIS
10.4 COOK MEDICAL INC.
ÌýÌý10.4.1 OVERVIEW
ÌýÌý10.4.2 FINANCIALS
ÌýÌý10.4.3 PRODUCT PORTFOLIO
ÌýÌý10.4.4 KEY DEVELOPMENTS
ÌýÌý10.4.5 BUSINESS STRATEGY
ÌýÌý10.4.6 SWOT ANALYSIS
10.5 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
ÌýÌý10.5.1 OVERVIEW
ÌýÌý10.5.2 FINANCIALS
ÌýÌý10.5.3 PRODUCT PORTFOLIO
ÌýÌý10.5.4 KEY DEVELOPMENTS
ÌýÌý10.5.5 BUSINESS STRATEGY
ÌýÌý10.5.6 SWOT ANALYSIS
10.6 JOHNSON & JOHNSON (ETHICON)
ÌýÌý10.6.1 OVERVIEW
ÌýÌý10.6.2 FINANCIALS
ÌýÌý10.6.3 PRODUCT PORTFOLIO
ÌýÌý10.6.4 KEY DEVELOPMENTS
ÌýÌý10.6.5 BUSINESS STRATEGY
ÌýÌý10.6.6 SWOT ANALYSIS
10.7 MEDTRONIC PUBLIC LIMITED COMPANY
ÌýÌý10.7.1 OVERVIEW
ÌýÌý10.7.2 FINANCIALS
ÌýÌý10.7.3 PRODUCT PORTFOLIO
ÌýÌý10.7.4 KEY DEVELOPMENTS
ÌýÌý10.7.5 BUSINESS STRATEGY
ÌýÌý10.7.6 SWOT ANALYSIS
10.8 SECQURE SURGICAL
ÌýÌý10.8.1 OVERVIEW
ÌýÌý10.8.2 FINANCIALS
ÌýÌý10.8.3 PRODUCT PORTFOLIO
ÌýÌý10.8.4 KEY DEVELOPMENTS
ÌýÌý10.8.5 BUSINESS STRATEGY
ÌýÌý10.8.6 SWOT ANALYSIS
10.9 TELA BIO, INC.
ÌýÌý10.9.1 OVERVIEW
ÌýÌý10.9.2 FINANCIALS
ÌýÌý10.9.3 PRODUCT PORTFOLIO
ÌýÌý10.9.4 KEY DEVELOPMENTS
ÌýÌý10.9.5 BUSINESS STRATEGY
ÌýÌý10.9.6 SWOT ANALYSIS
10.10 W. L. GORE & ASSOCIATES, INC.
ÌýÌý10.10.1 OVERVIEW
ÌýÌý10.10.2 FINANCIALS
ÌýÌý10.10.3 PRODUCT PORTFOLIO
ÌýÌý10.10.4 KEY DEVELOPMENTS
ÌýÌý10.10.5 BUSINESS STRATEGY
ÌýÌý10.10.6 SWOT ANALYSIS
Ìý
Ìý
*If Applicable.